iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray

This study is testing whether using a computer-based tool called iCAGES — which analyses a patient's tumour genes and medical images together — can guide doctors to better, more personalised cancer treatments for people with advanced or recurrent lung cancer or other advanced cancers. **You may be eligible if...** - You have been diagnosed with recurrent or metastatic lung cancer, or another advanced cancer - Your imaging records (CT/MRI scans) are available at the study hospital - You are between 18 and 70 years old - You are willing to sign a consent form **You may NOT be eligible if...** - You are over 70 or under 18 years old - You have a previous history of another malignant tumour - You are pregnant or breastfeeding - You have serious heart disease or other major conditions that could affect your prognosis Talk to your doctor to see if this trial is right for you.